Viewing Study NCT00861120


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-03-02 @ 10:05 PM
Study NCT ID: NCT00861120
Status: COMPLETED
Last Update Posted: 2012-10-26
First Post: 2009-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type
Sponsor: Vejle Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module